Industry stocks

Biotechnology Stocks on NYSE

Compare NYSE-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Emergent Biosolutions Inc (EBS)
Fair Value7.2% Upside Fair Analyst62.7% Upside Market Cap346.6 M P/E Yield0.0% HealthGreat
  NYSE
Lineage Cell Therapeutics Inc (LCTX)
Fair Value12.1% Upside Fair Analyst428.8% Upside Market Cap263 M P/E Yield0.0% HealthFair
  NYSE
AbbVie Inc (ABBV)
Fair Value-10.5% Downside Fair Analyst5.1% Upside Market Cap468.7 B P/E74.7x Yield2.6% HealthGreat
  NYSE
Actinium Pharmaceuticals Inc (ATNM)
Fair Value30.9% Upside Undervalued Analyst207.7% Upside Market Cap36.786 M P/E3.3x Yield0.0% HealthGreat
  NYSE
Armata Pharmaceuticals Inc (ARMP)
Fair Value-24.4% Downside Overvalued Analyst316.7% Upside Market Cap156.2 M P/E Yield0.0% HealthWeak
  NYSE
CEL-SCI Corp (CVM)
Fair Value46.5% Upside Undervalued Analyst635.3% Upside Market Cap29.901 M P/E Yield0.0% HealthFair
  NYSE
Perspective Therapeutics Inc (CATX)
Fair Value-7.9% Downside Fair Analyst315.1% Upside Market Cap337.9 M P/E Yield0.0% HealthWeak
  NYSE
Protalix Biotherapeutics Inc (PLX)
Fair Value-18.9% Downside Overvalued Analyst287.3% Upside Market Cap228.8 M P/E12.1x Yield0.0% HealthGreat
  NYSE
Theriva Biologics Inc (TOVX)
Fair Value15.1% Upside Fair Analyst983.2% Upside Market Cap10.592 M P/E Yield0.0% HealthWeak
  NYSE
Arcus Biosciences Inc (RCUS)
Fair Value-8.7% Downside Fair Analyst44.2% Upside Market Cap3.421 B P/E Yield0.0% HealthWeak
  NYSE
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
Fair Value7.7% Upside Fair Analyst43.2% Upside Market Cap2.243 B P/E Yield0.0% HealthWeak
  NYSE
Can Fite Biopharma Ltd ADR (CANF)
Fair Value55.4% Upside Bargain Analyst258.7% Upside Market Cap4.834 M P/E Yield0.0% HealthWeak
  NYSE
Matinas BioPharma Holdings Inc (MTNB)
Fair Value31.0% Upside Undervalued Market Cap2.601 M P/E Yield0.0% HealthFair
  NYSE
NanoViricides Inc (NNVC)
Fair Value-40.6% Downside Overvalued Analyst292.2% Upside Market Cap34.854 M P/E Yield0.0% HealthFair
  NYSE
Oragenics Inc (OGEN)
Fair Value30.0% Upside Undervalued Market Cap2.346 M P/E Yield0.0% HealthFair
  NYSE
Adc Therapeutics SA (ADCT)
Fair Value9.0% Upside Fair Analyst171.0% Upside Market Cap157 M P/E Yield0.0% HealthFair
  NYSE
Aeon Biopharma Inc (AEON)
Fair Value-2.3% Downside Fair Analyst486.5% Upside Market Cap13.069 M P/E Yield0.0% HealthFair
  NYSE
Annovis Bio Inc (ANVS)
Fair Value5.2% Upside Fair Analyst733.3% Upside Market Cap53.684 M P/E Yield0.0% HealthWeak
  NYSE
Serina Therapeutics Inc (SER)
Fair Value11.2% Upside Fair Analyst311.3% Upside Market Cap58.675 M P/E Yield0.0% HealthWeak
  NYSE
AIM ImmunoTech Inc (AIM)
Fair Value23.1% Upside Undervalued Market Cap6.563 M P/E Yield0.0% HealthWeak
  NYSE
Apimeds Pharma US Ltd (APUS)
Market Cap2.792 M P/E Yield0.0% HealthWeak
  NYSE
Azitra Inc (AZTR)
Fair Value27.0% Upside Undervalued Analyst354.3% Upside Market Cap10.339 M P/E Yield0.0% HealthWeak
  NYSE
Calidi Biotherapeutics Inc (CLDI)
Fair Value39.4% Upside Undervalued Market Cap4.102 M P/E Yield0.0% HealthWeak
  NYSE
Evommune Inc (EVMN)
Fair Value9.7% Upside Fair Analyst151.3% Upside Market Cap348.4 M P/E Yield0.0% HealthFair
  NYSE
Kairos Pharma Ltd (KAPA)
Fair Value31.5% Upside Undervalued Market Cap6.026 M P/E Yield0.0% HealthWeak
  NYSE
Maia Biotechnology Inc (MAIA)
Fair Value-1.2% Downside Fair Analyst775.9% Upside Market Cap83.331 M P/E Yield0.0% HealthWeak
  NYSE
OS Therapies Inc (OSTX)
Fair Value3.1% Upside Fair Analyst380.2% Upside Market Cap81.643 M P/E Yield0.0% HealthWeak
  NYSE
Pelthos Therapeutics Inc (PTHS)
Fair Value25.4% Upside Undervalued Analyst128.7% Upside Market Cap88.974 M P/E Yield0.0% HealthFair
  NYSE
Regentis Biomaterials Ltd (RGNT)
Fair Value-37.1% Downside Overvalued Analyst378.5% Upside Market Cap14.68 M P/E Yield0.0% HealthFair
  NYSE
Explore listed stocks on NYSE with company information and fair value data.